A cardinal feature of AD is the deposition of amyloid-beta, which is produced by the activity of beta-amyloid cleaving enzyme-1 (BACE), as certain studies have shown that targeted inhibition of BACE-1 regulates the expression of amyloid-beta, thereby reducing its burden [12,13]. The gene discussed is BACE1; the disease is Alzheimer disease.